Former ET co-host John Tesh revealed he that he far exceeded the wildest expectations of doctors who diagnosed him with cancer more than a decade ago - but he still lives with the disease.

The former 'Entertainment Tonight' co-host revealed in 2015 that he had been diagnosed with a rare form of prostate cancer ...

An investigational approach to diagnosis of prostate cancer uses sound waves to extract "bubbles of information" from cells. ...

Targeted ultrasound therapy offers a less invasive prostate cancer treatment designed to minimize disruption to daily life.

The James P. Allison Institute™ at The University of Texas MD Anderson Cancer Center today announced the appointment of four new members, Eric Gardner, Pharm.D., Ph.D., Betty Kim, M.D., Ph.D., Rodrigo ...

Kishan and colleagues found that men with PSA levels of 0.51-1.00 ng/mL had a reduction in mortality risk with the addition of hormone therapy (HR 0.72, 95% CI 0.54-0.96), as did those with PSA levels ...

MDT associated with improved progression-free, radiographic progression-free, castration resistance-free survival.

How fast a cancer is growing can greatly change options. Focal therapies, which don’t target the entire prostate, are best ...

First radiotherapeutic agent developed by Radiopharm Ventures, the joint venture between Radiopharm Theranostics and MD Anderson Cancer Center ...

Plastic particles were found at higher levels in tumor tissue than nearby noncancerous tissue, raising questions about the ...

Ochsner MD Anderson Cancer Center at The Gayle and Tom Benson Cancer Center in New Orleans announces a milestone in advanced ...

As rates of colon cancer continue to rise in young adults, the University of Texas MD Anderson Cancer Center is opening a new clinic designed to offer specialized care to those patients. The clinic, ...